Remove 2023 Remove Patent Application Remove Patent Law
article thumbnail

The UPC's first decision on infringement by equivalence (Plant-e v Bioo, UPC_CFI_239/2023)

The IPKat

In Plant-e v Bioo the UPC provided its first decision addressing the doctrine of equivalents in patent infringement proceedings ( UPC_CFI_239/2023 ). Case details: Plant-based fuel cells The dispute in UPC_CFI_239/2023 concerned EP2137782 , owned by Plant-e Knowledge B.V.

article thumbnail

Patent Application for Gilead’s Lenacapavir Opposed: Saving Generics of HIV Drugs?

SpicyIP

The looming threat is the pending patent applications by Gilead in India. A Look at the Pre-Grant Oppositions Gilead has multiple patent applications for Lenacapavir in India, including those seeking patents on its choline and sodium salts. and the oppositions raised against these applications.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CALL FOR TRYOUTS – USPTO National Patent Application Drafting Competition

IPilogue

2021-2022 was a big year for the Osgoode’s mooting team entry for the USPTO National Patent Application Drafting Competition. We invite you to participate in the tryouts for the 2022-2023 National Patent Application Drafting Competition ! About the National Patent Application Drafting Competition.

article thumbnail

Patent Law Exam 2023: Are you Smarter than a Law Student?

Patently-O

by Dennis Crouch The following is my patent law exam from this past semester. After talking again with Jane, EL decided to patent the device. He initially filed a provisional patent application in June 2020. The non-provisional patent application included the following two claims: 1. Question 3.

article thumbnail

Shaping the Future of Patent Law: The Amgen v. Sanofi Decision and Bite-Sized Monopolies

Patently-O

The Court held that Amgen’s patent claims were invalid due to a lack of enablement, as they failed to provide adequate guidance for making and using the claimed antibodies. — (2023) ( 21-757_k5g1 ). Sanofi case, while significant, may not come as a surprise to those familiar with the evolution of patent law.

article thumbnail

Thaler v. Comptroller-General: Supreme Court Affirms that an AI Cannot be an Inventor under UK Patent Law

Intepat

Thaler, the applicant, approached the UK Patent Office with two patent applications. At the heart of this case lies a critical examination of the UK Patent Act 1977, specifically Section 13(2). In the definitive judgement issued on 20 December 2023, the appeal lodged by Mr. Thaler was ultimately rejected.

article thumbnail

The IPKat EPO Boards of Appeal Year in Review 2023

The IPKat

This week, the UK supreme court finally rejected the appeal by Dr Thaler to have DABUS named as an inventor on a patent application. 25 sequence listing added to the pages of a divisional has now been issued ( OJ EPO 2023, A98 ). 26: Is it time for patent offices to enter the bioinformatic age? Looking beyond ST.26:

Invention 111